Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1982 1
1983 3
1984 3
1985 7
1986 3
1987 4
1988 6
1989 12
1990 5
1991 10
1992 15
1993 15
1994 19
1995 21
1996 21
1997 27
1998 27
1999 25
2000 46
2001 48
2002 71
2003 97
2004 101
2005 136
2006 169
2007 225
2008 246
2009 282
2010 324
2011 384
2012 473
2013 579
2014 682
2015 691
2016 777
2017 882
2018 958
2019 1158
2020 1403
2021 1715
2022 1935
2023 1942
2024 2176
2025 1019

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

16,736 results

Results by year

Filters applied: . Clear all
Page 1
Enteric neuronal Piezo1 maintains mechanical and immunological homeostasis by sensing force.
Xie Z, Rose L, Feng J, Zhao Y, Lu Y, Kane H, Hibberd TJ, Hu X, Wang Z, Zang K, Yang X, Richardson Q, Othman R, Venezia O, Zhakyp A, Gao F, Abe N, Vigeland K, Wang H, Branch C, Duizer C, Deng L, Meng X, Zamidar L, Hauptschein M, Bergin R, Dong X, Chiu IM, Kim BS, Spencer NJ, Hu H, Jackson R. Xie Z, et al. Among authors: dong x. Cell. 2025 May 1;188(9):2417-2432.e19. doi: 10.1016/j.cell.2025.02.031. Epub 2025 Mar 24. Cell. 2025. PMID: 40132579
Post-transcriptional regulation in archaea.
Li J, Liang Y, Dong X. Li J, et al. Among authors: dong x. Trends Microbiol. 2025 Mar 5:S0966-842X(25)00035-6. doi: 10.1016/j.tim.2025.02.004. Online ahead of print. Trends Microbiol. 2025. PMID: 40050166 Review.
Camrelizumab plus carboplatin and pemetrexed as first-line therapy for advanced non-squamous non-small-cell lung cancer: 5-year outcomes of the CameL randomized phase 3 study.
Zhou C, Chen G, Huang Y, Zhou J, Lin L, Feng J, Wang Z, Shu Y, Shi J, Hu Y, Wang Q, Cheng Y, Wu F, Chen J, Lin X, Wang Y, Huang J, Cui J, Cao L, Liu Y, Zhang Y, Pan Y, Zhao J, Wang L, Chang J, Chen Q, Ren X, Zhang W, Fan Y, He Z, Fang J, Gu K, Dong X, Jin F, Gao H, An G, Ding C, Jiang X, Xiong J, Zhou X, Hu S, Lu P, Liu A, Guo S, Huang J, Zhu C, Zhao J, Gao B, Chen Y, Hu C, Zhang J, Zhang H, Zhao H, Wang Z, Ma X, Shi W. Zhou C, et al. Among authors: dong x. J Immunother Cancer. 2024 Nov 27;12(11):e009240. doi: 10.1136/jitc-2024-009240. J Immunother Cancer. 2024. PMID: 39608979 Free PMC article. Clinical Trial.
16,736 results
You have reached the last available page of results. Please see the User Guide for more information.